Diagnosis, pathogenesis and treatment of Miller Fisher syndrome and related disorders: clinical significance of antiGQ1b IgG antibody

References

• Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl. Med 255,57–65 (1956).
   PubMed Web of Science ®Google Scholar
• The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35,1096–1104 (1985).
   PubMed Web of Science ®Google Scholar
• French Co-operative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann. Neural. 22, 753–761 (1987).
   PubMed Web of Science ®Google Scholar
• Hartung HP, Pollard JD, Harvey GK, Toyka K. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 18,137–153 (1995).
   PubMedGoogle Scholar
• Kusunoki S, Chiba A, Kon K et aIN- acetylgalactosaminyl GD la is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neural. 35,570–576 (1994).
   PubMed Web of Science ®Google Scholar
• Ho TW, Mishu B, Li CY eta]. Guillain- Barre syndrome in northern China. Relationship to Campy/obacterjEjuni infection and antiglycolipid antibodies. Brain 118,597–605 (1995).
   Google Scholar
• Kusunoki S, Iwamori M, Chiba A, Hitoshi S, Arita M, Kanazawa I. GMlb is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology47, 237–242 (1996).
   PubMed Web of Science ®Google Scholar
• Ho TW, Willison HJ, Nachamkin I etal AntiGDla antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neural. 45, 168–173 (1999).
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Hadden RDM, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. I Neuroimmunal 100, 74–97 (1999).
   PubMed Web of Science ®Google Scholar
• Kusunoki S. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies. Am. j Merl Sci 319,234–239 (2000).
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neural 31, 677–679 (1992). First report on the antiGQ113 IgG antibody in MFS.
   Google Scholar
• Willison HJ, Veitch J, Paterson G, Kennedy PGE. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. j Nemo'. Neurosurg. Psychiatry 56,204–206 (1993).
   Google Scholar
• Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T Frequent presence of antiGQ1b antibody in Fisher's syndrome. Neurology 43, 414–417 (1993).
   PubMed Web of Science ®Google Scholar
• Carpo M, Pedotti R, Loni F et al Clinical correlate and fine specificity of antiGQ1b antibodies in peripheral neuropathy. Neural. Sc]. 155,186-191 (1998).
   Google Scholar
• Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum antiGQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43,1911-1917 (1993). Important imrnunohistochemical study on the specific localization of GQ1b in the paranodal myelin of the cranial nerves innervating extraocular muscles.
   Google Scholar
• Yuki N. Acute paresis of extraocular muscles associated with IgG antiGQ1b antibody. Ann. Neural. 39,668-672 (1996)
   Google Scholar
• Sakurai Y, Kusunoki S, Mannen T Acute isolated ophthalmoplegia as a variant of Miller Fisher syndrome. Muscle Nerve 21, 1107 (1998)
   PubMedGoogle Scholar
• Suzuki T, Chiba A, Kusunoki S, Chikuda M, Fujita T, Misu K. AntiGQ1b ganglioside antibody and ophthalmoplegia of undetermined cause. BE j Ophthalmol 82,916–918 (1998).
   Google Scholar
• Kusunoki S, Chiba A, Kanazawa I. AntiGQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve22, 1071–1074 (1999).
   Google Scholar
• •Imrnunohistochemical study showing presence of GQ1b-positive primary sensory neurons.
   Google Scholar
• Yuki N, Susuki K, Hirata K. Ataxic Guillain-Barré syndrome with antiGQ1b antibody: relation to Miller Fisher syndrome. Neurology54,1851–1853 (2000).
   Google Scholar
• Kamakura K, Kaida K, Kusunoki S, Miyamoto N, Fukuda J, Motoyoshi K. Elevation in antiGQ1b, antiGTla and antiGT1b IgG antibodies in postinfectious acute ataxic neuropathy with oropharyngeal palsy but without ophthalmoplegia. j Neural 247,566–567 (2000).
   PubMedGoogle Scholar
• Bickerstaff E. Brain stem encephalitis: further observations on a grave syndrome with benign prognosis. BE Merl jii, 1384–1387 (1957).
   Google Scholar
• Yuki N, Sato S, Tsuji S eta]. An immunologic abnormality common to Bickerstaff's brainstem encephalitis and Fisher syndrome. j Neural Sc]. 118,83–87 (1993).
   Google Scholar
• •First report on the antiGQ1b IgG antibody and Bickerstaff's brainstem encephalitis.
   Google Scholar
• O'Leary CP, Veitch J, Durward WF, Thomas AM, Rees JH, Willison HJ. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GTla gangliosides. j Neural Neurosurg, fiychiatry61, 649–651 (1996).
   PubMed Web of Science ®Google Scholar
• Mizoguchi K, Hase A, Obi T etal. Two species of antiganglioside antibodies in a patient with a pharyngeal—cervical—brachial variant of Guillain-Barré syndrome. Neural Neurosurg. P9'cl-iiatry57, 1121–1123 (1994).
   Google Scholar
• Koga M, Yuki N, Ariga T, Morimatsu M, Hirata K. Is IgG antiGTla antibodyassociated with pharyngeal—cervical— brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? Neuroimmunal 86,74–79 (1998).
   Google Scholar
• Susuki K, Yuki N, Hirata K. Fine specificity of antiGQ1b IgG and clinical features. Neural Sc]. 185,5-9 (2001).
   Google Scholar
• Daune GC, Farrer RG, Dalakas MC, Quarles RII. Sensory neuropathy associatedwith monoclonal immunoglobulin M to GD lb ganglioside. Ann. Neural 31,683–685 (1992).
   PubMedGoogle Scholar
• Kusunoki S, Chiba A, Tai T, Kanazawa I. Localization of GM1 and GD lb antigens in the human peripheral nervous system. Muscle Nerve 16,752–756 (1993).
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Mashiko H, Mochizuki N etal Binding of antibodies against GM1 and GD lb in human peripheral nerve. Muscle Nerve 20,840–845 (1997).
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD lb. Ann. Neural 39,424–431 (1996).
   PubMed Web of Science ®Google Scholar
• Mitsui Y, Kusunoki S, Hiruma S etal Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human T-cell leukemia virus I infection. IVIuscle Nerve 22, 1461–1465 (1999).
   PubMed Web of Science ®Google Scholar
• Yako K, Kusunoki S, Kanazawa I. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. j Neural Sc]. 168,85-89 (1999).
   Google Scholar
• Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 745, 32–36 (1997).
   Google Scholar
• •Important biochemical analysis on GQ1b content of each cranial and peripheral nerve of humans.
   Google Scholar
• Willison HJ, O'Hanlon GM, Paterson G etal A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, Vl-18.j Clin. Invest. 97,1155-1164 (1996).
   Google Scholar
• Kuwabara S, Asahina M, Nakajima M eta]. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann. Neural 45,533–536 (1999).
   Google Scholar
• Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 343, 454–455 (1994).
   Google Scholar
• Plomp JJ, Molenaar PC, O'Hanlon GM eta]. Miller Fisher antiGQ1b antibodies: a-latrotoxin-like effects on motor end plates. Ann. Neural 45,189-199 (1999). Important study on the effects of the antiGQ113 antibodies on NMJs.
   Google Scholar
• O'Hanlon GM, Plomp JJ, Chakrabarti M eta]. AntiGQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124,893–906 (2001).
   Google Scholar
• Buchwald B, Bufler J, Carpo M etal Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neumlogy56, 67–74 (2001).
   PubMedGoogle Scholar
• ••Important study on the effects of theantiGQ113 antibodies on NMJs.
   Google Scholar
• Uncini A, Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block. Muscle Nerve 22,640–644 (1999).
   PubMedGoogle Scholar
• Hitoshi S, Kusunoki S, Tsuji S, Kanazawa I. AntiGD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons. Neurosci. Lett. 260,157-160 (1999).
   Google Scholar
• Kusunoki S, Hitoshi S, Kaida K, Arita M, Kanazawa I. Monospecific antiGD1b IgG is required to induce rabbit ataxic neuropathy. Ann. Neural. 45,400-403, (1999).
   Google Scholar
• Kusunoki S, Hitoshi S, Kaida K, Murayama S, Kanazawa I. Degeneration of rabbit sensory neurons induced bypassive transfer of antiGD lb antiserum. Neurosci. Lett. 273,33–36 (1999).
   Google Scholar
• Oka N, Kusaka H, Kusunoki S etal IgM M-protein with antibody activity against gangliosides with disialosyl residue in sensory neuropathy binds to sensory neurons. Muscle Nerve 19,528–530 (1996).
   PubMed Web of Science ®Google Scholar
• Willison HJ, O'Leary CP, Veitch J etal The clinical and laboratory features of chronic sensory ataxic neuropathy with antidisialosyl IgM antibodies. Brain 124, 1968–1977 (2001).
   PubMed Web of Science ®Google Scholar
• Yuki N, Yamada M, Koga M etal Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neural. 49,712-720 (2001).
   Google Scholar
• Odaka M, Yuki N, Hirata K, AntiGQ1b IgG antibody syndrome: clinical and immunological range. I Neural. Neurosurg. PTchiatry70, 50–55 (2001).
   Google Scholar
• Williams MH. The spectrum of IgG GQ1b syndrome: an unusual cluster. j Clin. Neurosci 8,315–318 (2001).
   Google Scholar
• Yuki N, Taki T, Inagaki Petal A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. Exp. Med 178,1771–1775 (1993).
   Google Scholar
• Oomes PG, Jacobs BC, Hazenberg MP, Banffer JR, van der Meche FG. AntiGM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neural 38,170–175 (1995).
   Google Scholar
• Kusunoki S, Chiba A, Hitoshi S etal AntiGal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 18,409–413 (1995).
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Shiina M, Kanazawa I. AntiGal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry. Neurology57, 736–738 (2001).
   PubMed Web of Science ®Google Scholar
• Yuki, Taki T, Takahashi M eta]. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campy/obacterjEjuni isolated from patients with Fisher's syndrome. Ann. Neural. 36,791-793 (1994).
   Google Scholar
• Jacobs BC, Endtz H, van der Meche FG etal Serum antiGQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neural. 37,260-264 (1995).
   Google Scholar
• Neisser A, Bernheimer H, Berger T, Moran AP, Schwerer B. Serum antibodies against gangliosides and Campy/obacterjejuni lipopolysaccharides in Miller Fisher syndrome. Infect. Iminun. 65,4038–4042 (1997).
   Google Scholar
• Goodyear CS, O'Hanlon GM, Plomp JJ etal Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campy/obacterjEjuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle—nerve preparations. j Cl/n. Invest 104,697–708 (1999).
   PubMed Web of Science ®Google Scholar
• •Important data supporting the molecular mimicry hypothesis as a mechanism for the induction of antiGQ113 antibodies.
   Google Scholar
• Koga M, Yuki N, Tai T, Hirata K. Miller Fisher syndrome and .themophilus influenzae infection. Neurology57,686–691 (2001).
   Google Scholar
• •Determination of a candidate agent of the antecedent respiratory infection of MFS.
   Google Scholar
• Chiba A, Kusunoki S, Kuwata S, Juji T, Shibata Y, Kanazawa I. HLA and antiGQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barre syndrome. Neuroiminunal 61,85–88 (1995).
   PubMed Web of Science ®Google Scholar
• van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing iv. immune globulin and plasma exchange in Guillain-Barré syndrome. N. Engl. Med. 326,1123–1129 (1992).
   Google Scholar
• Plasma Exchange/Sandoglobulin Guillain- Barre syndrome Trial Group. Randomised trial of plasma exchange, iv. immunoglobulin and combined treatments in Guillain-Barré syndrome. Lancet 349, 225–230 (1997).
   Google Scholar
• Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G antiGQ1b antibody from Fisher's syndrome: a new approach to treatment. Neurology 46, 1644–1651 (1996).
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Fukutake T, Hattori T Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. .1. Neural. Neurosurg. Psychiatry 72,680 (2002).
   Google Scholar
• Chida K, Takase S, Itoyama Y. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases. .1. Neural. Neurosurg. Psychiatiy 64,399–401 (1998).
   Google Scholar
• Yuki N. Successful plasmapheresis in Bickerstaff's brainstem encephalitis associated with antiGQ1b antibody. Neural. Sci. 131,108-110 (1995).
   Google Scholar
• Kikuchi M, Tagawa Y, Iwamoto H, Hoshino H, Yuki N. Bickerstaff's brainstem encephalitis associated with IgG antiGQ1b antibody subsequent to 11/1Ycoplasma pneumoniae infection: favorable response to immunoadsorption therapy. J. Child Neural. 12,403-405 (1997).
   Google Scholar
• Ozawa T, Onodera O, Inuzuka T, Soma Y, Tsuji S. Efficacy of early plasmapheresis in Bickerstaff's encephalitis. Inter Med. 37, 986–989 (1998).
   Google Scholar
• Shimokawa M, Shinoda T, Takahashi M, Watabiki S. Successful plasmapheresis in the not-so-benign Bickerstaff's brain stem encephalitis associated with antiGQ1b antibody. Thar. Apher 2,240–242 (1998).
   Google Scholar
• Fujisato H, Amemiya M, Hayashi Y etal Treatment with steroids and double filtration plasmapheresis for a case of antiGQ1b antibody-positive Bickerstaff's encephalitis. Thar Apher 3,72–74 (1999).
   PubMedGoogle Scholar
• Fox RJ, Kasner SE, Galetta SL, Chalela JA. Treatment of Bickerstaff's brainstem encephalitis with immune globulin. Neural. Sci. 178,88–90 (2000).
   PubMed Web of Science ®Google Scholar